• 28 Nov 2025

Advances in Small Molecule Drug Development, Boston 2026

  • Events

Join us on February 11th 2026 at the Cambridge Innovation Centre, Cambridge, for a one-day meeting focused on the latest advances in small molecule drug development, exploring the discovery, synthesis, and delivery of novel small molecule therapeutics and conjugates.

The event encourages open discussion between academia, biotech, and pharma to share knowledge and strengthen collaboration across the development pipeline.

Key topics include:

  • Novel chemistry-enabled modalities and conjugates
  • Scalable synthesis and process development
  • Digital, data, and automation in chemical design
  • Analytical science and in-process control
  • Future trends in small molecule R&D

Featured Speakers

Plenary speaker:

Additional speakers:

  • Yexenia E. Nieves Quinones, Principal Scientist – Process Chemistry, Pfizer
  • Karli Holman, Principal Scientist – Lead Discovery Chemistry, GSK
  • Philippe Bolduc, Senior Scientist – Synthetic Medicine Design, Biogen
  • John Traverse, Executive Director – Process Chemistry, Kymera Therapeutics
  • Sami Svanbäck, CEO, The Solubility Company
  • Rob Crook, Director of Chemical Science, CatSci

Badge Registration Form

Advances in Small Molecule Drug Development Boston 2026

This field is for validation purposes and should be left unchanged.
Name(Required)

Please note the deadline to register for catering is February 4th. Late registrants should contact the organisers directly with dietary requirements.

Who Should Attend

This conference is for scientists, researchers, and industry professionals involved in the discovery, development, and manufacture of small molecules and conjugates. It offers an opportunity to share experiences, learn from peers, and build connections across different parts of the development journey.

Who should attend:

  • Senior leaders in biotech and pharma
  • Discovery and process chemists
  • Analytical scientists and formulation specialists
  • Digital, data, and automation experts
  • Academic researchers and group leaders

Join us to explore how science, technology, and interdisciplinary collaboration are reshaping the future of drug development.

Date, Location and Venue

February 11th 2026, 09:30 – 17:00

Mosaic, Cambridge Innovation Center (CIC)

3rd Floor, 245 Main Street

Cambridge, MA 02142

United States

Sponsors and Partners

Please contact Dan Croucher (dan.croucher@catsci.com) for sponsorship information.

Organising Committee

Dan Croucher: dan.croucher@catsci.com

Carlos Cote: carlos.cote@catsci.com

Stay informed on LinkedIn

Resources & Insights

  • 15 Jan 2026
  • Jordan Fletcher
Peptide Design in Contemporary DMTA Cycles: How DMTA Drives Translational Refinement
  • Design Make Test Analyse
  • DMTA
  • Peptides
  • Thought Leaders
  • 12 Jan 2026
  • Loïc Roux
Is Fragmented Discovery the Silent Saboteur of Complex Medicines?
  • Design-Make-Test
  • DMTA
  • Drug Discovery
  • Thought Leaders
  • 8 Dec 2025
  • Alison Gordon, Kathy Dodgson, Ryan Mordue, Tom Miller, Vesna Vetma O'Leary
PROductive TACtics Streamlined, multifaceted approaches to unlocking PROTAC® screening insights
  • Bioscience
  • Case Studies
489 KB
  • 2 Dec 2025
CatSci x BRAINBiocatalysts Conference 2026
  • Events